Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Cancel Anytime
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

A COVID-19 patient wearing oxygen mask waits inside a vehicle to be attended and admitted in a dedicated COVID-19 government hospital in Ahmedabad, India, on April 22, 2021.

Ajit Solanki/The Associated Press

A variant that appears to be wreaking havoc in India has been detected in Canada and sparked a temporary ban on direct passenger flights from India and Pakistan on Thursday. But experts say it’s too early to know how concerning this new version of the COVID-19 virus is.

The variant – named B.1.617 – has so far been classified as a “variant of interest” by the World Health Organization, rather than a “variant of concern,” the term attached to the variants first detected in the United Kingdom, Brazil and South Africa.

Which COVID-19 variants are in Canada?

Raywat Deonandan, an epidemiologist with the University of Ottawa, said Thursday that a variant of interest is one that is “suspected” to either be more contagious than the initial strain, cause more severe disease, or escape the protection offered by vaccines.

Story continues below advertisement

A variant of interest can become a variant of concern if more evidence emerges that it does one or more of those things, he added.

Here’s what we know about the new variant:

HOW TRANSMISSIBLE IS B.1.617?

India is dealing with massive surges in COVID-19 activity – there were 300,000 new cases reported Wednesday with 2,000 deaths linked to the virus – but the Indian government has not confirmed the new variant is fuelling the current wave.

Prof. Deonandan said the variant appears to be responsible for about 60 per cent of cases in India’s most populated region, which would suggest a higher transmissibility.

He said it’s “probably around 20 to 30 per cent,” more contagious, but added that experts still don’t know if the variant causes more severe disease.

Indian COVID-19 cases surge again as it struggles with a health system overwhelmed by patients

“It may be a little less bad than B.1.1.7 [the variant first detected in the U.K.],” Prof. Deonandan said. “But our biggest concern is: If it becomes common here, are we then fighting off essentially another B.1.1.7?”

Zain Chagla, an infectious-disease expert with McMaster University, said it’s important to flag this variant as one of interest because it does seem account for more and more of India’s caseload.

Story continues below advertisement

But, he added, other factors – including the country’s densely populated urban centres and multigenerational homes with poorly ventilated spaces – may be contributing to how quickly it’s spreading there.

“Is it because of situations that lead to high levels of transmission and superspreading, or is there something biologically different about this variant?” Dr. Chagla said. “Or is it some combination of the two?”

Alain Lamarre, an immunology and virology professor at the Institut national de la recherche scientifique in Quebec, doesn’t think the new variant of interest is more concerning than the variants first detected in South Africa and Brazil.

He said he’s more concerned about the variant first discovered in the U.K., which is “clearly more transmissible and more virulent.”

WILL CURRENT VACCINES WORK AGAINST THE NEW VARIANT?

The variant first detected in India has a double mutation on the spike protein gene, which our current COVID-19 vaccines target. But experts say there’s no evidence right now that the approved vaccines won’t work against it.

Prof. Deonandan said the variant may diminish vaccine efficacy, “at least a little bit,” because that’s what we’ve seen with the variants of concern so far.

Story continues below advertisement

But, he added, that doesn’t mean efficacy will drop from 95 per cent to zero, for example.

Prof. Deonandan likened the coronavirus’s spike protein to the licence plate on a car, with vaccines giving our cells that plate number so they know to keep it out when they see it.

“But if the licence plate has changed, will the cell still recognize the car?” he said. “So the question is: Has an entire digit on the plate changed, or is it just a smudge on the corner?”

Prof. Deonandan added that the mRNA vaccines seem to be adept at catching different versions of the virus by targeting many aspects of the spike protein.

“So, they may say: ‘Look out for all licence plates beginning with the letter B,’ rather than this specific licence plate,” he said.

Prof. Lamarre said adapting mRNA vaccines such as those by Moderna and Pfizer-BioNTech to new variants would be faster and easier than altering other types of inoculations.

Story continues below advertisement

“The approval process will be quicker as well because the proof of concept has been done and we know that the mRNA vaccines are safe and efficient,” he said.

WHERE HAS THE VARIANT APPEARED IN CANADA?

The B.C. Ministry of Health said Thursday there had been 39 cases of the B.1.617 lineage in the province on April 4, before it was identified as a variant of interest.

Quebec confirmed Wednesday what’s believed to be the province’s first case of the new variant, causing Premier François Legault to urge the federal government to tighten restrictions on air travel.

Mr. Legault said the premiers of Ontario, Alberta and British Columbia were among those behind a letter sent to the federal government expressing concerns about new variants coming into the country.

Deputy chief public health officer Howard Njoo said Thursday that Canada will be making adjustments at the border for incoming flights “very soon.”

B.C.’s top doctor, Bonnie Henry, said some of the 39 cases of the variant in that province were directly related to travel from India, but others had no travel link.

Story continues below advertisement

The cases were seen “at different times over the last month and a half to two months,” Dr. Henry added.

CAN WE CALL THE VARIANT A “DOUBLE MUTANT?”

While some have dubbed the variant a “double mutant,” Dr. Chagla said that’s a misnomer that conjures up false images of a supervirus.

The earlier variants of concern don’t have a single mutation, Dr. Chagla said, but instead a set of them that change the virus in certain ways.

Having two mutations on the spike protein doesn’t necessarily mean the variant is more dangerous than one that has a single mutation on that gene, Dr. Chagla added.

“That’s a terrible term,” he said of the double-mutant label. “When you see double mutations as compared to single mutations people get freaked out, but in reality many of these are combinations of mutations.”

With files from Jacob Serebrin in Montreal

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies